In CRC, depletion of METTL14 is associated with poor prognosis (Chen et al., 2020b; Yang et al., 2020c), which is different from the methylated enzymes METTTL3 and KIAA1429 in liver cancer. Here, METTL14 is linked to colorectal carcinoma.